BioSpace News Archive

Adoption of recombinant cell culture supplements by biopharmaceutical manufacturers and research institutes has increased significantly for the development of novel drugs and treatment.

Alpine 4 Technologies’ (OTCQB:ALPP) subsidiaries Morris Sheet Metal Corp, Deluxe Sheet Metal, Inc., and Quality Circuit Assembly, Inc. today announced that they have collectively secured several new health care building projects for its hospital clientele to build isolation rooms and medical-grade air sensor and monitoring PO’s.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has completed its preclinical development of a novel formulation containing cannabinoids which have demonstrated anti-tumor properties in studies held at the company’s High Throughput Screening (HTS) research facility in Israel, which were focused on gastrointestinal cancers.

ECRI, an independent trusted voice in healthcare improving the safety, quality, and cost-effectiveness of care, and RLDatix, the leading global provider of intelligent patient safety solutions, announce a new collaboration to meet the needs of care teams in the midst of the COVID-19 pandemic.

As the COVID-19 global pandemic continues to run its course, some medical supply distributors utilize Fishbowl Warehouse® to help them navigate complex inventory issues to deliver personal protective equipment and supplies to healthcare facilities working the front lines.

Orchard Laboratories, headquartered in West Bloomfield, Mich. (7901 Orchard Lake Road, Suite 100) is the first private laboratory in Michigan to provide rapid testing for COVID-19 with new, state-of-the art equipment using the Emergency Use Authorization (EUA) protocol for the ThermoFisher 7500DX Platform.

Beaumont Health’s Research Institute is launching America’s largest serological testing study to help answer many questions surrounding the spread of COVID-19 and potentially help treat patients battling the virus.

Spectrum Solutions, LLC today announced the FDA Emergency Use Authorization (EUA) approval for the immediate use of saliva in COVID-19 testing exclusively using the Spectrum SDNA-1000 saliva collection device which has been proven to protect and preserve RNA used for the detection of infection.

PMT Partners announced today the Oxylator®, a small compact patientresponsive portable resuscitation – ventilation device, was safely used to treat a patient with COVID19 pneumonia in the intensive care unit (ICU).

Select Medical Holdings Corporation, will release the financial results for its first quarter ended March 31, 2020 on Thursday, April 30, 2020 after the market closes.